Metrics to compare | 000661 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship000661PeersSector | |
|---|---|---|---|---|
P/E Ratio | −81.4x | 15.6x | −0.3x | |
PEG Ratio | 0.68 | 0.50 | 0.00 | |
Price/Book | 1.3x | 2.2x | 2.6x | |
Price / LTM Sales | 2.6x | 2.6x | 3.0x | |
Upside (Analyst Target) | 43.8% | 40.9% | 54.6% | |
Fair Value Upside | Unlock | 24.1% | 8.6% | Unlock |
Changchun High-Tech Industry (Group) Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China. The company offers recombinant human growth hormone injection; recombinant human follicle stimulating hormone for injection; herpes zoster vaccines; live attenuated varicella vaccine; freeze-dried nasal spray live attenuated influenza; xueshuanxinmaining tablet; and yinhuamiyanling tablet. It also develops real estate properties. The company was founded in 1993 and is based in Changchun, China.